Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial-Reference-Cited by-同舟云学术

Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial

Published:2018-04 Issue:4 Volume:5 Page:e147-e160
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Cox Sharon E,Ellins Elizabeth A,Marealle Alphonce I,Newton Charles R,Soka Deogratias,Sasi Philip,Luca Di Tanna Gian,Johnson William,Makani Julie,Prentice Andrew M,Halcox Julian P,Kirkham Fenella J

Publisher

Elsevier BV

Subject

Hematology

Reference40 articles.

1. Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania;Makani;PLoS One,2011

2. Influence of sickle hemoglobinopathies on growth and development;Platt;N Engl J Med,1984

3. Nutritional status, hospitalization and mortality among patients with sickle cell anemia in Tanzania;Cox;Haematologica,2011

4. Malnutrition in sickle cell anemia: implications for infection, growth, and maturation;Hyacinth;J Soc Behav Health Sci,2013

5. The role of nutrition in sickle cell disease;Hyacinth;Nutr Metab Insights,2010

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kısa Bağırsak Sendromunda Malnutrisyonun Önlenmesi ve Tedavisinde Beslenmenin Rolü: Geleneksel Derleme;Gazi Sağlık Bilimleri Dergisi;2024-08-30

2. Endothelial dysfunction in Sickle Cell Disease: Strategies for the treatment;Nitric Oxide;2024-08

3. Models of care for sickle cell disease in low-income and lower-middle-income countries: a scoping review;The Lancet Haematology;2024-04

4. Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (BRAIN SAFE II): Protocol for a single-arm open label trial;2024-01-13

5. Hydroxyurea Therapy for Neurological and Cognitive Protection in Pediatric Sickle Cell Anemia in Uganda (Brain Safe Ii): Protocol for a Single-Arm Open Label Trial;2024